533 Extended treatment-free interval with excellent life more than two years after autologous dendritic cell vaccine therapy targeting HTLV-1 Tax for previously treated adult T-cell leukemia/lymphoma: The follow-up kinetics of cytotoxic T lymphocytes and HTLV-1 viral load. (September 2015) - Suehiro, Y.; Hasegawa, A.; Iino, T.; Fujioka, E.; Watanabe, N.; Tanosaki, R.; Utsunomiya, A.; Choi, I.; Matsuoka, M.; Shiratsuchi, M.; Teshima, T.; Akashi, K.; et al.